ID 2127 - Jeżyna krzewiasta

PL: Jeżyna krzewiasta
EN: Rubus fructicosus L.(Common name: Blackberry)
Pdf: various food(s)/food constituent(s) not supported by pertinent human data

1.4. Ulga w przypadku podrażnienia górnych dróg oddechowych (ID 1730, 2127, 2137, 2332, 2380, 2435)

The claimed effects are “respiratory health” and “respiratory system health”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effects refer to relief in case of irritation in the upper respiratory tract, which could be assessed if adequate validated questionnaires were available.
The Panel considers that relief in case of irritation in the upper respiratory tract is a beneficial physiological effect.

2.4. Ulga w przypadku podrażnienia górnych dróg oddechowych (ID 1730, 2127, 2137, 2332, 2380, 2435)

Most of the references provided in relation to these claims were textbooks, narrative reviews and monographs which did not provide any original data which could be used for the scientific substantiation, or assessed the effects of food(s)/food constituent(s) other than those for which the specific claims are proposed, and/or health outcomes (e.g. treatment of infectious diseases, treatment of influenza) unrelated to the claimed effect. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claims.
No human studies which investigated the effects of the food(s)/food constituent(s) on measures of relief of irritation in the upper respiratory tract were provided in relation to any of the claims evaluated in this section.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of the claims evaluated in this section and relief of irritation in the upper respiratory tract.

Warunki i możliwe ograniczenia stosowania oświadczenia

Folia (Leaves) 4 to 5 g dried drug equivalent per day